Evidence map›Paper›PMID 39507978›Full record

ArticleSichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition2024

[Isongifolene Improves Crohn's Disease-Like Colitis in Mice by Reducing Apoptosis of Intestinal Epithelial Cells].

Ting Duan, Zhijun Geng, Jingjing Yang, Lixia Yin, Mingxi Sun, Shunyin Wang, Xiaofeng Zhang, Jing Li, Jianguo Hu, Guoyu Lu

Abstract readEnglish Abstract
In one paragraph

Article in Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Ting Duan( 233000) Department of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Zhijun Geng( 233000) Department of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Jingjing Yang( 233000) Department of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Lixia Yin( 233000) Department of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Mingxi Sun( 233000) Department of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Shunyin Wang( 233000) Department of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Xiaofeng Zhang( 233000) Department of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Jing Li( 233000) Department of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Jianguo Hu( 233000) Department of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.
Guoyu Lu( 233000) Department of Emergency, The First Affiliated Hospital of Bengbu Medical University, Bengbu 233000, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: To investigate the effect and molecular mechanism of isolongifolene (ISO) on the apoptosis of intestinal epithelial cells and 2,4,6-trinitrobenzenesulfonic acid (TNBS)-induced Crohn's disease (CD)-like colitis in mice. Methods: In the animal experiments, mice were randomly assigned to the wild type (WT) group, TNBS group and TNBS+ISO group, with 8 mice in each group. Colitis models of mice were established in the TNBS group and the TNBS+ISO group by rectal injection of TNBS. After modeling, the mice in the TNBS+ISO group were given ISO intervention via intragastric gavage (10 mg/kg), and the other two groups were given the same amount of normal saline via intragastric gavage. The mice were sacrificed on the 7th day. The changes in body mass, disease activity scores (DAI), and the colon length of mice were measured, and transepithelial electrical resistance (TEER) of the colon tissues was determined. The score of colon inflammation was calculated according to HE staining. The levels of intestinal mucosal inflammatory factors, including tumor necrosis factor alpha (TNF-α), interferon (IFN)-γ, interleukin (IL)-1β, and IL-6, were measured by RT-PCR and ELISA. The apoptosis of colon tissue cells was determined by TUNEL assay. The expressions of apoptotic proteins (cleaved caspase-3/caspase-3 and Bax), an anti-apoptotic protein (Bcl-2), and tight junction proteins (ZO-1 and claudin-1) were detected by Western blot and immunofluorescence. In the cell experiment, TNF-α was used to induce intestinal epithelial cell Caco-2 apoptosis model, which was treated with ISO. Then, intervention with the AMPK inhibitor Compound C was given. TUNEL assay, Western blot assay, and immunofluorescence assay were performed to measure apoptosis and the expression of apoptosis proteins in the Caco-2 cells. Gene Ontology (GO) enrichment analysis was performed to predict the biological function of ISO. Then, the mechanism involved was verified by examination of the mice and Caco-2 cells. Western blot was performed to determine the expression levels of p-AMPK/AMPK and p-PGC1α in the colon tissues from the mice of different groups and Caco-2 cells. The apoptosis of the cells was determined by TUNEL assay. Results: According to the results of the animal experiment, ISO could alleviate experimental colitis and intestinal barrier dysfunction, leading to improvements in body mass loss, colon length shortening, DAI score, inflammatory rating, and TEER values (all Conclusion: ISO reduces intestinal epithelial cell apoptosis at least in part by activating AMPK/PGC1α signaling pathway, thereby alleviating TNBS-induced intestinal barrier dysfunction and CD-like colitis in mice.

Indexed as

ApoptosisColitisCrohn DiseaseEpithelial CellsIntestinal MucosaTrinitrobenzenesulfonic AcidAnimalsCaspase 3Claudin-1ColonDisease Models, AnimalInterferon-gammaInterleukin-1betaMiceProto-Oncogene Proteins c-bcl-2Tumor Necrosis Factor-alphaCaspase 3Claudin-1Interferon-gammaInterleukin-1betaProto-Oncogene Proteins c-bcl-2Tjp1 protein, mouseTrinitrobenzenesulfonic AcidTumor Necrosis Factor-alphaZonula Occludens-1 ProteinAMPK/PGC1αCrohn's diseaseIntestinal barrierIntestinal epithelial cell apoptosisIsolongifolene

Identifiers

PMID39507978
PMCPMC11536240

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.